Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity

被引：0
|
作者：
Norbert Kociok
Tim U. Krohne
Vassiliki Poulaki
Antonia M. Joussen
机构：
[1] University of Cologne,Department of Vitreoretinal Surgery, Center for Ophthalmology
[2] University of Cologne,Center for Molecular Medicine (CMMC)
[3] Harvard Medical School,Massacussetts Eye and Ear Infirmary
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2007年 / 245卷
关键词：
Retina; Geldanamycin; Neovascularization; Retinopathy of prematurity; Kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：258 / 266
页数：8
相关论文
共 50 条
  • [41] AAV-mediated expression of VEGF peptides inhibits retinal neovascularization (NV) in a mouse model of retinopathy of prematurity (ROP)
    Deng, W
    Yan, Z
    Berns, KI
    Hauswirth, WW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U196 - U196
  • [42] Short Hairpin RNA-Mediated Knockdown of VEGFA in Muller Cells Reduces Intravitreal Neovascularization in a Rat Model of Retinopathy of Prematurity
    Wang, Haibo
    Smith, George W.
    Yang, Zhihong
    Jiang, Yanchao
    McCloskey, Manabu
    Greenberg, Kenneth
    Geisen, Pete
    Culp, William D.
    Flannery, John
    Kafri, Tal
    Hammond, Scott
    Hartnett, M. Elizabeth
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 183 (03): : 964 - 974
  • [43] Captopril Reduces Retinal Neovascularization in a Mouse Model of ROP
    Misrak Tadesse
    Yun Yan
    Panitan Yossuck
    Rosemary D Higgins
    Pediatric Research, 1999, 45 : 70 - 70
  • [44] Captopril reduces retinal neovascularization in a mouse model of ROP
    Tadesse, M
    Yan, Y
    Yossuck, P
    Higgins, RD
    PEDIATRIC RESEARCH, 1999, 45 (04) : 70A - 70A
  • [45] In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy
    Le Gat, L
    Gogat, K
    Bouquet, C
    Saint-Geniez, M
    Darland, D
    Van Den Berghe, L
    Marchant, D
    Provost, A
    Perricaudet, M
    Menasche, M
    Abitbol, M
    GENE THERAPY, 2003, 10 (25) : 2098 - 2103
  • [46] Treatment of retinopathy of prematurity
    Clark, David
    Mandal, K.
    EARLY HUMAN DEVELOPMENT, 2008, 84 (02) : 95 - 99
  • [47] Treatment of retinopathy of prematurity
    Wagner, RS
    Nelson, LB
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 1997, 34 (02) : 75 - 75
  • [48] In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy
    L Le Gat
    K Gogat
    C Bouquet
    M Saint-Geniez
    D Darland
    L Van Den Berghe
    D Marchant
    A Provost
    M Perricaudet
    M Menasche
    M Abitbol
    Gene Therapy, 2003, 10 : 2098 - 2103
  • [49] Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity
    Fu, Zhongjie
    Meng, Steven S.
    Burnim, Samuel B.
    Smith, Lois E. H.
    Lo, Amy C. Y.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (05): : 529 - 538
  • [50] The treatment of retinopathy of prematurity
    Wykes, W.
    Flavahan, P.
    SCOTTISH MEDICAL JOURNAL, 2013, 58 (03) : 129 - 129
12345